State-of the-Art Review : Endogenous Heparin Activity Deficiency and Atherosclerosis

Graham DW , Lyon TP , Gofman JW, et al. Blood lipids and atherosclerosis. II. The influence of heparin upon lipoprotein metabolism. Circulation 1951 ;4 :666-76.

Engelberg H. , Dudley A. , Freeman L. An improved method for the determination of plasma heparin. J Lab Clin Med 1955;46:653-9.

Engelberg H. Plasma heparin levels in normal man. Circulation 1961;23:578-81.

Engelberg H. Plasma heparin levels in normal man: correlation with serum cholesterol and very low density lipoproteins. Circulation 1961;23:573-7.

Engelberg H. Human endogenous lipemia clearing factor. Am J Physiol 1955;181:2-5.

Engelberg H. Human endogenous lipemia clearing activity: studies of lipolysis and effects of inhibitors. J Biol Chem 1956;222:601-6.

Engelberg H. In vitro studies of human plasma lipolytic activity before and after oral fat intake. J Appl Physiol 1957;11:2-6.

Engelberg H. Human endogenous plasma lipemia clearing after intravenous fat emulsions. J Appl Physiol 1958;13: 292-8.

Engelberg H. Human endogenous plasma lipemia clearing activity: observations in 482 individuals. J Appl Physiol 1958;13:375-82.

Karpe F. , Olivecrona T. , Waldius G., et al. Lipoprotein lipase in plasma after an oral fat load: relation to free fatty acids. J Lipid Res 1992 ;33:975-84.

Durrington PN How HDL protects against atheroma. Lancet 1993 ;342 :1315-6.

Engelberg H. Heparin and the atherosclerotic process. Pharmacol Rev 1984;36:91-110.

Engelberg H. Update on the relation of heparin to atherosclerosis and its complications. Semin Thromb Hemost 1988;14:88-105.

Engelberg H. Heparin and the prevention of atherosclerosis : basic research and clinical application. New York : Wiley-Liss, 1990.

Auverx JH , Babirak SP , Fujimoto WY, et al. Defective enzyme protein in lipoprotein lipase deficiency . Eur J Clin Invest 1989;19:433-7.

Beg O. , Meng MS , Skarlatos SL, et al. Lipoprotein lipase Bethesda: a single amino acid substitution leads to abnormal heparin binding and to loss of enzyme activity. Proc Natl Acad Sci USA 1990;87:3474-8.

Anfinsen CB , Boyle E. , Brown R. The role of heparin in lipoprotein metabolism . Science 1952;115:583-6.

Cupp M. , Bensadoun A. , Melford K. Heparin decreases the degradation rate of lipoprotein lipase in adipocytes . J Biol Chem 1987;262:6343-8.

Vannier C. , Ailhaud G. Biosynthesis of lipoprotein lipase in cultured adipocytes. II. Processing, subunit assembly and intracellular transport. J Biol Chem 1989;264:13206-16.

Saxena U. , Klein MG , Goldberg IJ Transport of lipoprotein lipase across endothelial cells. Proc Natl Acad Sci USA 1991;88:2254-8.

Simpson HS , Williamson CM , Olivecrona T., et al. Postprandial lipemia, fenofibrate and coronary artery disease . Atherosclerosis 1990;85:193-202.

Patsch JR , Miesenbock G. , Hopperwieser T., et al. Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arterioscler Thromb 1992; 12:1336-45.

Uiterwaal Cspm , Grobee DE , Witteman Jcm, et al. Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis . Ann Intern Med 1994 ;121 :576-83.

Ryer JE , Howard G. , Craven TE , Bond MG , Hagaman AP , Crouse JR III. Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects. Stroke 1992 ;23:823-8.

Cohn JS , Postprandial lipid metabolism. Curr Opin Lipidol 1994 ;5 :185-90.

Jacobsson KG , Lindahl U. Attempted determination of endogenous heparin in blood [Abstract 0195] Thromb Haemost 1979;42:84.

Cavari S. , Stramoccia L. , Vanucchi S. , Endogenous heparinase-sensitive anticoagulant activity in human plasma . Thromb Res 1992;67:157-65.

Simionescu M. , Simionescu N. Functions of the endothelial cell surface . Annu Rev Physiol 1986;48:279-93.

Skutelsky F. , Danon D. Redistribution of surface anionic sites on the luminal front of blood vessel endothelium after interaction with polycationic ligand. J Cell Biol 1976;71: 232-8.

Ghinea N. , Leabu M. , Muresan V. Cellular and molecular events in atherogenesis: fourth US-Romanian workshop on biomedical research. Reported by Magno G. Arteriosclerosis 1986;6:242-4.

Gorog P. , Born Gvr. Increased uptake of circulating low density lipoproteins and fibrinogen by arterial walls after removal of sialic acids from the endothelial surface . Br J Exp Pathol 1982;63:447-55.

Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med 1986;314:488-500.

Thornton SC , Mueller SN , Levine EM Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science 1983;222:623-5.

Stary HC , Chandler AB , Glagov S., et al. A definition of initial fatty streak and intermediate lesions of atherosclerosis : a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb 1994;14:840-56.

Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's . Nature 1993;362:801-9.

Adams DH , Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration . Lancet 1994;343: 831-6.

Springer TA Traffic signals for lymphocyte recirculation and leukocyte emigration. Cell 1994 ;76:301-14.

Foxall C. , Watson SR , Dobenko D., et al. The three members of the selectin receptor family recognize a common carbohydrate epitope, the Sialyl-Lewis oligosaccharide. J Cell Biol 1992; 117:895-902.

Nelson RM , Ceccioni D. , Roberts WG , Aruffo A. , Linhardt RJ , Bevilacqua MP Heparin oligosaccharides bind L- and P-selectins and inhibit acute inflammation . Blood 1993;82: 3253-8.

Handa K. , Nudelman ED , Stroud MR , Shiozama T. , Hakomori SI Selectin GMP-140 (C062, PADGEM) binds to Sialosyl-Lea and Le x and sulfated glycans modulate this binding. Biochem Biophys Res Commun 1991;181:123-30.

Tangelder GJ , Arfors K-E. Inhibition of leukocyte rolling in venules by sulfated polysaccharides. Fed Proc 1987;46: 1542.

Lindbom L. , Xie X. , Raud J. , Hedquist P. Chemoattractant-induced firm adhesion of leukocytes to vascular endothelium in vivo is critically dependent on initial leukocyte rolling. Acta Physiol Scand 1992;146:415-21.

Lasky LA Combinatorial mediators of inflammation. Curr Opin Cell Biol 1993;3:366-8.

Miller MD , Krangel MS Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 1992;12:17-46.

Wiederman CJ , Kowald E. , Reinische N., et al. Monocyte haptotaxis induced by the RANTES chemokine. Curr Opin Cell Biol 1993;3:735-9.

Valente AJ , Fowler SR , Sprague EA , Kelley JL , Suenram CA , Schwartz CJ Initial characterization of a peripheral blood mononuclear cell chemoattractant derived from cultured arterial smooth muscle cells. Am J Pathol 1984;117: 409-13.

Mazzone T. , Jensen M. , Chait A. Human arterial wall cells secrete factors that are chemotactic for monocytes . Proc Natl Acad Sci USA 1983;80:5094-7.

Rollins BJ , Yoshimura T. , Leonard EJ , Pober JS Cytokineactivated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1. Am J Pathol 1990;136: 1229-33.

Humphrey DM , McManus LM , Satouchi K. , Hanohan DJ , Pinckard RN Vasoactive properties of acetyl glycerol ether phosphorylcholine and analogues. Lab Invest 1982; 46:422-7.

Kubes P. , Suzuki M. , Grainger DN Platelet active factor-induced microvascular dysfunction: role of adherent leukocytes. Am J Physiol 1990 ;258:G158-63.

Hocking D. , Furo TJ , Johnson A. Dextran sulfate and heparan sulfate inhibit platelet activating factor-induced pulmonary edema. J Appl Physiol 1992 ;72:179-85.

Diccianni MB , Mistry MJ , Hug K., et al. Inhibition of phospholipase A 2 by heparin. Biochim Biophys Acta 1990;1046: 242-8.

Dua R. , Cho W. Inhibition of human secretory class II PLA2 by heparin. Eur J Biochem 1994;221:481-90.

Heller RA , Kronke M. Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol 1994;126:5-9.

Silvestro L. , Ruiken C. , Sommer F., et al. Platelet activating factor-induced endothelial cell expression of adhesion molecules and modulation of surface glycocalyx evaluated by electron microscopy chemical analysis . Thromb Hemost 1994;20:214-22.

Tipping PG , Hancock WW Production of tumor necrosis factor and interleukin-1 by macrophages from human atherosclerotic plaques. Am J Pathol 1993;142:1721-8.

Hasuda DJ , Stricker J. , Simon PL , Young PR Processing of precursor interleukin-1B and inflammatory disease. J Biol Chem 1990;265:6318-22.

Jeannin P. , Delnisty Y. , Gosset P., et al. Histamine induces interleukin-8 secretion by endothelial cells. Blood 1994;84: 2229-33.

Yla-Hertualla S. , Sumuverosi H. , Karkola K., et al. Glycosaminoglycans in normal and atherosclerotic human coronary arteries. Lab Invest 1986;54:402-7.

Hollman J. , Schmidt A. , Bassewitz DB, et al. Relationship of sulfated glycosaminoglycans and cholesterol content in normal and arteriosclerotic human aorta. Arteriosclerosis 1989;9:154-8.

Seifert PS , Kazatchkine MD The complement system in atherosclerosis. Atherosclerosis 1988;73:91-104.

Weiler JM , Edens RE , Linhardt RJ , Kapelanski DP Heparin and modified heparin inhibit complement activation in vivo . J Immunol 1992; 148:3210-5.

Platt JL , Vercellotti GM , Lindman BL, et al. Release of heparan sulfate from endothelial cells: implications for pathogenesis of hyperacute rejection. J Exp Med 1990;171: 1363-8.

Simonson MB Endothelins: multifunctional renal peptides . Physiol Rev 1993;73:375-402.

Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-64.

Cooke JP , Tsao P. Cellular mechanisms of atherogenesis and the effects of nitric oxide. Curr Opin Cardiol 1992;7: 799-804.

Kourembanas S. , McMillan LP , Leung GK , Fuller DV Nitric oxide regulates the expression of vasoconstrictors by vascular endothelial cells under both normoxia and hypoxia. J Clin Invest 1993;92:99-104.

Nabel EG , Selwyn AP , Ganz P. Large coronary arteries in humans are responsive to changing blood flow: an endothelium dependent mechanism that fails in patients with atherosclerosis . J Am Coll Cardiol 1990;16:349-56.

Celermaier DS , Sorenson KE , Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis . Lancet 1992;340: 1111-5.

Zieher AM , Drexler H. , Wollschlager H. , Just H. Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis . Circulation 1991 ;84 :1984-92.

Yokokowa K. , Takara H. , Kohno M., et al. Heparin regulates endothelin production through endothelial-derived nitric oxide in human endothelial cells. J Clin Invest 1993 ;92: 2080-5.

Light Jr JT , Bellan JA , Roberts MP, et al. Heparin treatment enhances the recovery of neoendothelial acetylcholine-induced vascular relaxation after balloon catheter injury in the rabbit aorta. Circulation 1993;88(suppl 2):413-9.

Schini VS , Catovsky S. , Durante W. , Scott-Burden T. , Schafer AI , Vanhoutte PM Thrombin inhibits production of nitric oxide synthase in vascular smooth muscle cells. Am J Physiol 1993;264:H611-6.

Campbell JH , Campbell GR Endothelial cell influences on vascular smooth muscle phenotypes . Annu Rev Physiol 1986;48:295-306.

Campbell JR , Campbell GR The macrophage as an initiator of atherosclerosis . Clin Exp Pharmacol Physiol 1991 ;18 : 81-4.

Okazaki H. , Majesky MW , Harker LA , Schwartz SM Regulation of PDGF ligand and receptor gene expression by alpha thrombin in vascular smooth muscle cells. Circ Res 1992;71:1285-93.

Clowes AW , Karnovsky MJ Suppression by heparin of smooth muscle cell proliferation in injured arteries . Nature 1977;265:625-7.

Thyberg J. , Hedin V. , Sjolund M., et al. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 1990 ;10:695-9.

Zaragoza R. , Battle-Tracy KM , Owen NE Heparin inhibits Na +-H+ exchange in vascular smooth muscle cells. Am J Physiol 1990;258:C46-53.

Kenagy RD , Nikkari ST , Welgus HG , Clowes AW Heparin inhibits the induction of 3 matrix metalloproteases (stromelysin, 92kD gelatinase, and collagenase) in primate arterial smooth muscle cells . J Clin Invest 1994 ;93 :1987-93.

Galis Z. , Sukhova G. , Libby P. Evidence for presence of activated matrix metalloproteases in human atherosclerotic plaques [Abstract 3836]. FASEB J 1994 ;8:Abst. 3836.

Rosen EM , Goldberg ID , Kecinsky BM, et al. Smooth muscle cells release a scatter factor which binds to heparin. In Vitro Cell Devel Biol 1989;25:163-73.

Ottlinger ME , Pukac LA , Karnovsky MJ Heparin inhibits mitogen-activated protein kinase in rat vascular smooth muscle cells. J Biol Chem 1993;268:19173-6.

Majack RA , Cook SC , Bornstein P. Platelet derived growth factor and heparin-like glycosaminoglycans regulate thrombospodin synthesis and deposition in the matrix. J Cell Biol 1985;101:1059-70.

Tina Au TP , Kenagy RD , Clowes AW Heparin selectively inhibits the transcription of tissue-type plasminogen activator in primate arterial smooth muscle cells during mitogenesis. J Biol Chem 1992 ;267:3438-44.

Fager G. , Camejo G. , Bondjers G. The PDGF-A chain contains an amino acid sequence that specifically binds to heparin. Scand J Clin Lab Invest 1990 ;199:33-6.

Rosenberg RD Vascular smooth muscle proliferation: basic investigations and new therapeutic approaches. Thromb Haemost 1993;70:10-6.

Reilly CF , Kindy MS , Brown RE, et al. Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle. J Biol Chem 1989;264:6990-5.

Edelman ER , Pukac LA , Karnovsky MJ Protamine and protamine-insulin exacerbate the vascular response to injury . J Clin Invest 1993;91:2308-13.

Herman IM Endothelial cell matrices modulate smooth muscle cell growth, contractile phenotype, and sensitivity to heparin. Hemostasis 1990;20(suppl 1):166-77.

McCaffrey TA , Nicholson AC , Szabo PE , Weksler ME , Weksler BB Aging and arteriosclerosis: the increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased PDGF-like activity. J Exp Med 1988;167:163-74.

Edwards IJ , Wagner WD Cell surface heparan sulfate proteoglycans and chondroitin sulfate proteoglycans of arterial smooth muscle cells. Am J Pathol 1992;140:193-205.

Flory DM , Partharathy N. , Edwards IJ , Wagner WD Reduction in cell surface heparan sulfate octasaccharide sequences in cultured smooth muscle cells of pigeons with spontaneous atherosclerosis [Abstract] . Circulation 1993; 88:94.

Gallagher JT , Lyon M. , Stewart WP Structure and function of heparan sulfate proteoglycans. Biochem J 1986 ;236:313-25.

Esko JD , Stewart TE , Taylor WH Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc Natl Acad Sci 1985;82:3197-201.

Keller KL , Brauer PR , Keller JM Isolation of Swiss 3T3 cell variants with altered heparan sulfate . Exp Cell Res 1988;179:137-58.

Keller KL , Keller JM , Moy JN Heparin sulfates from Swiss mouse 3T3 and SV3T3 cells: O-sulfate differences . Biochemistry 1980;19:2529-36.

Kaner RJ , Iozzo RV , Ziale Z. , Kefalides NA Inhibition of proteoglycan synthesis in human endothelial cells after infection with herpes simplex virus-1 in vitro. Am J Resp Cell Mol Biol 1990;2:423-31.

Key NS , Platt JL , Vercellotti GM Various endothelial cell proteoglycans are susceptible to cleavage by neutrophils . Arterioscler Thromb 1992;12:836-42.

Redini F. , Tixier JM , Petitou M. , Choay J. , Robert L. , Hornebeck W. Inhibition of leucocyte elastase by heparin and its derivative. Biochem J 1988;252:515-9.

Geller RL , Ihrcke NS , Platt JL Release of endothelial cell-associated heparan sulfate proteoglycans by activated T cells. Transplantation 1994;57:770-4.

Hansson GK , Bondjers G. , Nilsson L-A. Plasma protein accumulation in injured endothelial cells. Exp Mol Pathol 1979;30:13-26.

Schwartz CJ , Valente AJ , Sprague EA , Kelley JL , Nerem RM The pathogenesis of atherosclerosis: an overview. Clin Cardiol 1991;14:11-6.

Radhakrishnamurthy B. , Ruiz HA , Dalferes Jr ER , Srinivasan SR , Foster TA , Berenson GS Studies of arterial wall glycosaminoglycans and collagen during experimental regression of atherosclerotic lesions in cynomolgous monkeys. Lab Invest 1982;47:153-9.

Hollman J. , Schmidt A. , von Bassewitz D-B. , Budduke E. Relationship of sulfated glycosaminoglycans and cholesterol content in normal and atherosclerotic human aorta. Arteriosclerosis 1989 ;9:154-8.

Volker W. , Schmidt A. , Oortmann W. , Broszey T. , Faber V. , Buddecke E. Mapping of proteoglycans in atherosclerotic lesions. Eur Heart J 1990;11(suppl E):29-40.

Murata K. , Yokoyama T. Acidic glycosaminoglycans, lipid and water contents in human coronary arterial branches. Atherosclerosis 1982;45:53-65.

Gorog P. , Pearson JD Surface determinants of low density lipoprotein uptake by endothelial cells . Atherosclerosis 1984;53:21-9.

Booth Reg , Martin JF , Honey AC , Hassall DG , Beesley JE , Moncada S. Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. Atherosclerosis 1989;76:257-68.

Hueper WC Atherosclerosis: the anoxemia theory. Arch Pathol 1944;38:162-71, 245-85, 350-64.

Martin JF , Booth Rfg , Moncada S. Arterial wall hypoxia following thrombosis of the vasa vasorum is an initial lesion in atherosclerosis. Eur J Clin Invest 1991;21:355-9.

Karlinsky JB , Rounds S. , Farber HW Effects of hypoxia on heparan sulfate in bovine aortic and pulmonary artery endothelial cells. Circ Res 1992;71:782-9

Engelberg H. Serum lipemia: an overlooked cause of tissue hypoxia. Cardiology 1983;70:273-9.

Joyner CR , Horwitz O. , Williams PG Effect of lipemia upon tissue oxygen tension in man. Circulation 1960;22: 901-7.

Swank RL , Nakamura H. Oxygen availability in brain tissues after lipid meals. Am J Physiol 1960;198:217-20.

Ditzel J. , Dyerberg J. The oxyhemoglobin dissociation curve in patients with familial hyperchylomicronemia . J Lab Clin Med 1977;89:573-80.

Halliwell B. Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis . Br J Exp Pathol 1989;70:737-57.

Smith C. , Mitchinson JM , Aruoma OI, et al. Stimulation of lipid peroxidation of hydroxyl radical generation by the contents of human atherosclerotic lesions. Biochem J 1992; 286:901-5.

Berliner JA , Haberland ME The role of oxidized LDL in atherogenesis. Curr Opin Lipidol 1993;4:373-81.

Grant D. , Long WF , Williamson FB Pericellular heparans may contribute to the protection of cells from free radicals. Med Hypoth 1987;23:67-77.

Hiebert LM , Liu J-M. Dextran sulphates protect porcine arterial endothelial cells from free radical injury. Hum Exp Toxicol 1993; 12:1-7.

Brestel EP , McClain EJ A mechanism for inhibition of luminol-dependent neutrophil chemiluminescence by polyanions. J Immunol 1983;131:2515-9.

Daugherty A. , Rateri DL , Heinecke JW Human atherosclerotic lesions contain myleoperoxidase, a phagocytic enzyme that catalyzes oxidation reactions [Abstract 155]. Circulation 1993;88.

Grant D. , Long WF , Williamson FB A potentiometric study of the interaction of heparin with metal cations . Biochem J 1992;285:477-80.

Ross MA , Long WF , Williamson FB Inhibition by heparin of Fe-catalyzed free radical peroxidation of lineolenic acid. Biochem J 1992;286:717-20.

Stemerman MB Hemostasis, thrombosis, and atherogenesis . Atheroscler Rev 1979;6:105-46.

Schwartz CJ , Valente AJ , Kelley JL , Sprague EA , Edwards EH Thrombosis and the development of atherosclerosis : Rokitansky revisited. Semin Thromb Hemost 1988; 14:89-95.

Nachman RL Thrombosis and atherogenesis: molecular connections . Blood 1992;79:1897-906.

Loscalzo J. The relation between atherosclerosis and thrombosis . Circulation 1992;86(suppl 3):95-9.

Nelson S. , Jeske W. , Hoppenstaedt D. , Fareed J. Tissue factor inhibitor release after the administration of low molecular weight heparin and synthetic sulfated agents [Abstract 1211]. FASEB J 1993;7.

Gori AM , Athanazio M. , Francesca M., et al. Monocyte tissue factor is influenced by heparin [Abstract 2013]. Thromb Hemost 1993;69.

Gorog P. , Piper J. , Ridler CD , Kovacs IB Heparin, both unfractionated and low molecular weight, inhibit physiologically relevant platelet reactivity in native blood in vitro [Abstract 849]. Thromb Haemost 1991 ;65.

Prisco B. , Paniccia R. , Gensini GF, et al. Effect of low dose heparin treatment on fibrinolysis in patients with previous myocardial infarcts. Haemostasis 1993 ;23:308-13.

Engelberg H. Low dose intermittent heparin therapy decreases plasma fibrinogen levels. Semin Thromb Haemost 1991;17:211-5.

Engelberg H. , Kuhn R. , Steinman M. A controlled study of the effect of intermittent heparin therapy on the course of human coronary atherosclerosis. Circulation 1956 ;13 :489-98.

Bottiger LE , Carlson LA , Oro L. Long-term heparin treatment in ischemic heart disease: effects on clinical condition and plasma lipids . Acta Med Scand 1967;182:245-53.

Neri-Serneri GG , Gensini GF , Carnovali M. , Rovelli F. , Pirelli S. , Fortini A. Effectiveness of low-dose heparin in prevention of myocardial infarction. Lancet 1987 ;1:937-42.